Kliničke studije za Limfom u državi Maryland
21 studija za Limfom traži sudionike na lokacijama u državi Maryland.
Gradovi u državi Maryland
Službeni tekst studije (engleski)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT03258567Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 3 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT01441089CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 1/2
Od 3 do 39 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05442515Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 do 120 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT00006518Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 do 110 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT00923507Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 1/2
Od 18 do 120 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT03223610Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06398457A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Maryland Oncology Hematology, Silver Spring
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07221500Collection of Tissue Samples for Cancer Research
- Johns Hopkins University, Baltimore
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
2 Months · Oba spola · Ažurirano 16. ruj 2026. · NCT00900198CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
U tijeku regrutacijaFaza 1/2
12 Months – 21 Years · Oba spola · Ažurirano 11. ruj 2026. · NCT04870944Sample Collection and Tracking for the Developmental Therapeutics Clinic
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 do 120 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT03269578Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Bethesda
U tijeku regrutacijaFaza 3
Od 18 do 18 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07509151Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
- Walter Reed National Military Medical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 4 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07652580Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 5 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT05237986Vaccine Responses in Patients With B Cell Malignancies
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 4
Od 18 do 90 godina · Oba spola · Ažurirano 4. kol 2026. · NCT05170399DALY II USA/ MB-CART2019.1 for DLBCL
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT04792489A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- National Institute of Health, Bethesda
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. srp 2026. · NCT05131022Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 1. lip 2026. · NCT05663502Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 do 120 godina · Oba spola · Ažurirano 27. svi 2026. · NCT06856226Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 18. svi 2026. · NCT01790152A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 20. ožu 2026. · NCT04830137Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.